News
Eli Lilly (NYSE: LLY) was an unstoppable bet in the past few years, but LLY stock finally started plateauing in the latter ...
11don MSN
There are significant questions on how the order can be implemented, and if companies can raise prices on already approved ...
Hosted on MSN13d
Eli Lilly's Zepbound Outperforms Wegovy In New Obesity Trial, But Trump's Drug Pricing Plan Keeps Retail Traders WaryEli Lilly and Co's obesity drug Zepbound led to greater ... President Donald Trump’s announcement that he plans to sign an ...
3d
GlobalData on MSNWegovy and Zepbound costs capped at $200 in new Evernorth programmeEvernorth said that through direct negotiations with Novo Nordisk and Eli Lilly, patients’ monthly copay costs for Wegovy (semaglutide) and Zepbound (tirzepatide) will not exceed $200. Wegovy has a ...
The president said his executive order will require pharmaceutical companies to price drugs in the U.S. in line with the ...
LONDON (Reuters) -U.S. President Donald Trump's executive order on drug pricing threatens Roche's planned $50 billion ...
5don MSN
Novo Nordisk’s new top executive will need to help the company close the gap with Eli Lilly, fend off emerging rivals and ...
8don MSN
The county joins municipalities across the country suing Eli Lilly, CVS Caremark, and others for sky-high prices.
President Trump said he would sign an executive order to base U.S. drug prices on what other countries pay — usually far less ...
President Donald Trump's executive order mandates drugmakers to lower prices to match those in affluent nations, threatening ...
President Trump, who has vowed to lower drugs prices by as much as 80 per cent ... Huge US companies — think AbbVie, Eli ...
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results